Froestl W[au] - Search Results

Year	Number of Results
1990	1
1993	3
1995	2
1997	2
1998	4
1999	8
2000	4
2001	10
2002	7
2003	4
2004	9
2005	8
2006	3
2007	3
2008	2
2009	1
2010	3
2011	6
2012	4
2013	2
2014	4
2016	1
2017	1
2021	0

1

Cognitive enhancers (nootropics). Part 1: drugs interacting with receptors.

Froestl W, Muhs A, Pfeifer A. Froestl W, et al. J Alzheimers Dis. 2012;32(4):793-887. doi: 10.3233/JAD-2012-121186. J Alzheimers Dis. 2012. PMID: 22886028 Review.

2

Ligands for expression cloning and isolation of GABA(B) receptors.

Froestl W, Bettler B, Bittiger H, Heid J, Kaupmann K, Mickel SJ, Strub D. Froestl W, et al. Farmaco. 2001 Jan-Feb;56(1-2):101-5. doi: 10.1016/s0014-827x(01)01003-5. Farmaco. 2001. PMID: 11347948 Review.

3

Ligands for expression cloning and isolation of GABA(B) receptors.

Froestl W, Bettler B, Bittiger H, Heid J, Kaupmann K, Mickel SJ, Strub D. Froestl W, et al. Farmaco. 2003 Mar;58(3):173-83. doi: 10.1016/s0014-827x(03)00018-1. Farmaco. 2003. PMID: 12620413 Review.

4

Cognitive enhancers (nootropics). Part 2: drugs interacting with enzymes. Update 2014.

Froestl W, Muhs A, Pfeifer A. Froestl W, et al. J Alzheimers Dis. 2014;42(1):1-68. doi: 10.3233/JAD-140402. J Alzheimers Dis. 2014. PMID: 24903780 Review.

5

Cognitive enhancers (nootropics). Part 2: drugs interacting with enzymes.

Froestl W, Muhs A, Pfeifer A. Froestl W, et al. J Alzheimers Dis. 2013;33(3):547-658. doi: 10.3233/JAD-2012-121537. J Alzheimers Dis. 2013. PMID: 23042218 Review.

6

Cognitive enhancers (Nootropics). Part 1: drugs interacting with receptors. Update 2014.

Froestl W, Muhs A, Pfeifer A. Froestl W, et al. J Alzheimers Dis. 2014;41(4):961-1019. doi: 10.3233/JAD-140228. J Alzheimers Dis. 2014. PMID: 24898652 Review.

7

Novel GABA(B) receptor positive modulators: a patent survey.

Froestl W. Froestl W. Expert Opin Ther Pat. 2010 Aug;20(8):1007-17. doi: 10.1517/13543776.2010.506480. Expert Opin Ther Pat. 2010. PMID: 20645682 Review.

8

The development of medications for alcohol-use disorders targeting the GABAB receptor system.

Agabio R, Maccioni P, Carai MA, Gessa GL, Froestl W, Colombo G. Agabio R, et al. Among authors: froestl w. Recent Pat CNS Drug Discov. 2012 Aug;7(2):113-28. doi: 10.2174/157488912800673137. Recent Pat CNS Drug Discov. 2012. PMID: 22574677 Review.

9

Cognitive enhancers (Nootropics). Part 3: drugs interacting with targets other than receptors or enzymes. Disease-modifying drugs. Update 2014.

Froestl W, Pfeifer A, Muhs A. Froestl W, et al. J Alzheimers Dis. 2014;42(4):1079-149. doi: 10.3233/JAD-141206. J Alzheimers Dis. 2014. PMID: 25061058 Review.

10

Cognitive enhancers (nootropics). Part 3: drugs interacting with targets other than receptors or enzymes. disease-modifying drugs.

Froestl W, Pfeifer A, Muhs A. Froestl W, et al. J Alzheimers Dis. 2013;34(1):1-114. doi: 10.3233/JAD-121729. J Alzheimers Dis. 2013. PMID: 23186990 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results